Premature cardiovascular deaths
Keywords:
Premature cardiovascular deathsAbstract
-
References
Stroh van Deventer B, du Toit-Prinsloo L, van Niekerk C. Postmortem testing in young individuals: what the clinical medical practitioners need to know. S Afr Med J 2022;112(12):886-889.
Stroh van Deventer B, du Toit-Prinsloo L, van Niekerk C. Cardiovascular death: what do the genes say? S Afr Med J 2022;112(12):885.
Marais AD, Blom DJ, Raal FJ. Familial hypercholesterolaemia in South Africa : a reminder. Editorial. 2021;111(8):700-701.
Wilemon KA, Patel J, Aguilar-Salinas C, et al. Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia. A Global Call to Action. JAMA Cardiology JAMA Cardiol. 2020;5(2):217-229.
Firth JC, Marais AD. Familial hypercholesterolaemia: The Groote Schuur Hospital Experience. S Afr Med. J 2008;98(2):99-104.
Thompson GR, Blom DJ, Marais AD, Seed M, Pilcher GJ, Raal FJ. Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol. Eur Heart J. 2018;39(14):1162-1168.
Marais AD. Dysbetalipoproteinemia: An extreme disorder of remnant metabolism. June Curr Opin Lipidol 2015; 26(4):292-297.
Schaefer EJ, Santos RD Asztalos BF. Marked HDL deficiency and premature coronary heart disease. Curr Opin Lipidol. 2010;21(4): 289–297.
Vanakker OM, Hemelsoet D, de Paepe A. Hereditary connective tissue diseases in young adult stroke: a comprehensive synthesis. Stroke Res Treatment 2011:712903
Morentin B, Callado LF. Sudden cardiac death associated to substances of abuse and psychotropic drugs consumed by young people: A population study based on forensic autopsies. Drug Alcohol Depend 2019;201:23-28.
Schmied C, Borjesson M. Sudden cardiac death in athletes. J Internal Med 2013;275:93-103.
Link MS. Commotio cordis: sudden death due to chest wall impact in sports. Heart 1999;81:109–110
Downloads
Published
Issue
Section
License
Copyright (c) 2023 A D Marais, D J Blom, F J Raal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
